Ru Li

机构：Stony Brook School, Genomix Biotech (India), Stony Brook University, Sun Chemical (United States) · ORCID：0000-0001-9054-2089

发表论文 100 篇 · 总被引 2036 次 · h-index 23

代表论文

• Neoadjuvant and adjuvant toripalimab for locoregionally advanced nasopharyngeal carcinoma: a randomised, single-centre, double-blind, placebo-controlled, phase 2 trial (2024 · The Lancet Oncology · 被引 65)
• The Potential Effect of General Anesthetics in Cancer Surgery: Meta-Analysis of Postoperative Metastasis and Inflammatory Cytokines (2023 · Cancers · 被引 57)
• Coordinated Regulation of Myeloid-Derived Suppressor Cells by Cytokines and Chemokines (2022 · Cancers · 被引 35)
• Targeted regulated cell death with small molecule compounds in colorectal cancer: Current perspectives of targeted therapy and molecular mechanisms (2023 · European Journal of Medicinal Chemistry · 被引 21)
• Neutrophils Culture in Collagen Gel System (2022 · Frontiers in Immunology · 被引 15)
• Effect and mechanisms of shikonin on breast cancer cells in vitro and in vivo (2024 · BMC Complementary Medicine and Therapies · 被引 11)